IL-4, IL-10, IL-13, and TGF-β from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 164, Issue 7, 2000, Pages 3563-3572

  Young, Deborah A ^a   Lowe, Leslie D ^a   Booth, Susan S ^a   Whitters, Matthew J ^a   Nicholson, Lindsay ^b   Kuchroo, Vijay K ^b   Collins, Mary ^a  

^a PFIZER INC   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; TRANSFORMING GROWTH FACTOR BETA;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA HYBRIDIZATION; SPLEEN CANCER;

EID: 0034177889     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.7.3563     Document Type: Article

References (48)

1. Ando, D. G., J. Clayton, D. Kono, J. L. Urban, and E. E. Sercarz. 1989. Encephalitogenic T cells in the B 10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine type. Cell. Immunol. 124:132.
2. Zamvil, S., P. Nelson, J. Trotter, D. Mitchell, R. Knobler, R. Fritz, and L. Steinman. 1985. T cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 317:355.
3. Zamvil, S. S., and L. Steinman. 1990. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8:579.
4. + T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J. Exp. Med. 188:1883.
5. Mosmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
6. + T cells. Annu. Rev. Immunol. 12:635.
7. Olsson, T. 1995. Cytokine producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis. Neurology 45(Suppl. 6):S11.
8. Kennedy, M. K., D. S. Torrance, K. S. Picha, and K. M. Mohler. 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:2496.
9. Bettelli, E., M. Prabhu Das, E. D. Howard, H. L. Weiner, R. A. Sobel, and V. K. Kuchroo. 1998. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161:3299.
10. Falcone, M., A. J. Rajan, B. R. Bloom and C. F. Brosnan. 1998. A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice. J. Immunol. 160:4822.
11. Racke, M. K., A. Bonomo, D. E. Scott, B. Cannella, A. Levine, C. S. Raine, E. M. Shevach, and M. Rocken. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1961.
12. Cannella, B., Y. L. Gao, C. Brosnan, and C. S. Raine. 1996. IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J Neurosci. Res. 45:735.
13. Chen, Y., V. K. Kuchroo, J. Inobe, D. A. Hafler, and H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237.
14. Kuchroo, V. K., M. Prabdhu Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
15. Khoruts, A., S. D. Miller, and M. K. Jenkins. 1995. Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells. J. Immunol. 155:5011.
16. Lafaille, J. J., F. Van de Keere, A. L. Hsu, J. L. Baron, W. Haas, C. S. Raine, and S. Tonegawa. 1997. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 2:307.
17. Cua, D. J., D. R. Hinton, and S. A. Stohlman. 1995. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. J. Immunol. 155:4052.
18. Falcone, M., and B. R. Bloom. 1997. A T helper cell 2 (TH2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J. Exp. Med. 185:901.
19. Kuchroo, V. K., J. M. Greer, D. Kaul, G. Ishioka, A. Franco, A. Sette, R. A. Sobel, and M. B. Lees. 1994. A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire. J. Immunol. 153:3326.
20. Nicholson, L. B., A. Murtaza, B. P. Hafler, A. Sette, and V. K. Kuchroo. 1997. A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens. Proc. Natl. Acad. Sci. USA 94:9279.
21. Donaldson, D. D., M. J. Whitters, L. J. Fitz, T. Y. Neben, H. Finnerty, S. H. Henderson, R. M. O'Hara, Jr., D. R. Beier, K. J. Turner, C. R. Wood, and M. Collins. 1998. The murine IL-13 receptor α2: molecular cloning, characterization, and comparison with murine IL-13 receptor α1. J. Immunol. 161:2317.
22. Lockhart, D. J., H. Dong, M. C. Byrne, M. T. Follettie, M. V. Gallo, M. S. Chee, M. Mittmann, C. Wang, M. Kobayashi, H. Horion, and E. L. Brown. 1996. Expression monitoring by hybridization to high-density oligonucleotide assays. Nat. Biotechnol. 14:1675.
23. Tuohy, V. K., Z. Lu, R. A. Sobel, R. A. Laursen, and M. B. Lees. 1988. A synthetic peptide from myelin proteolipid induces experimental allergic encephalomyelitis. J. Immunol. 141:1126.
24. Sobel, R.A., B. W. Blanchette, A. K. Bhan, and R. B. Colvin. 1984. The immunopathology of experimental allergic encephalomyelitis. I. Quantitative analysis of inflammatory cell in situ. J. Immunol. 132:2393.
25. Traugott, U. 1989. Detailed analysis of early immunopathologic events during lesion formation in acute experimental autoimmune encephalomyelitis. Cell. Immunol. 119:114.
26. Van der Veen, R. C., and S. A. Stohlman. 1993. Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10. J. Neuroimmunol. 48:2213.
27. Nagelkerken, L., B. Blauw, and M. Tielemans. 1997. IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice. Int. Immunol. 9:1243.
28. Rott, O., B. Fleischer, and E. Cash. 1994. Interleukin 10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1434.
29. Samoilova, E. B., J. L. Horton, and Y. Chen. 1998. Acceleration of experimental autoimmune encephalomyelitis in interleukin 10 deficient mice: role of interleukin 10 in disease progression and recovery. Cell. Immunol. 188:118.
30. Shaw, M. K., J. B. Lorens, A. Dhawan, R. DalCanto, H. Y. Tse, A. B. Tran, C. Bonpane, S. L. Eswaran, S. Brocke, N. Sarvetnick, et al. 1977. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1711.
31. Jovanovic, D. V., J. A. DiBattista, J. Martel-Pelletier, F. C. Jolicoeur, Y. He, M. Zhang, F. Mineau, and J. Pelletier. 1998. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-β and TNF-α, by human macrophages. J. Immunol. 160:3513.
32. Cash, E., A. Minty, P. Ferrara, D. Caput, D. Fradelizi, and O. Rott. 1994. Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J. Immunol. 153:4258.
33. Zurawski, G., and J. E. de Vries. 1994. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15:19.
34. Minty, A., P. Ferrara, and D. Caput. 1997. Interleukin 13 effects on activated monocytes lead to novel cytokine secretion profiles intermediate between those induced by interleukin-10 and by interferon-γ. Eur. Cytokine Network 8:189.
35. Zurawski, S. M., P. Chomara, O. Djosson, C. Bidaud, A. N. J. McKenzie, P. Miossec, J. Banchereau, and G. Zurawski. 1995. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J. Biol. Chem. 270:13869.
36. Letterio, J. J., and A. B. Roberts. 1998. Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 16:137.
37. Johns, L. D., K. C. Flanders, G. E. Ranges, and S. Sriram. 1991. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1. J. Immunol. 147:1792.
38. Racke, M. K., S. Dhib-Jalbut, B. Cannella, P. S. Albert, C. S. Raine, and D. E. McFarlin. 1991. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-B. J. Immunol. 146: 3012.
39. Karpus, W. J., and R. H. Swanborg. 1991. CD4 suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-β. J. Immunol. 146:1163.
40. Santambrogio, L., G. M. Hochwald, B. Saxena, C. Leu, J. E. Martz, J .A. Carlino, N. H. Ruddle, M. A. Palladino, L. I. Gold, and G. J. Thorbecke. 1993. Studies on the mechanisms by which transforming growth factor-β (TGF-β) protects against allergic encephalomyelitis. J. Immunol. 151:1116.
41. Johns, L. D., and S. Srian. 1993. Experimental allergic encephalomyelitis: neutralizing antibody to TGF-β1 enhances the clinical severity of the disease. J. Neuroimmunol. 47:1.
42. Racke, M. K., B. Cannella, A. P. Sporn, C. S. Raine, and D. E. McFarlin. 1992. Evidence of endogenous regulatory function of transforming growth factor-β1 in experimental allergic encephalomyelitis. Int. Immunol. 4:615.
43. Sanderson, C. J. 1994. Interleukin-5. In Guidebook to Cytokines and Their Receptors. N. A. Nicola, ed. Oxford Univ. Press, London, p. 49.
44. Simpson, R. J., and J. C. Renaud. 1994. Interleukin 9. In Guidebook to Cytokines and Their Receptors, N. A. Nicola, ed. Oxford Univ. Press, London, p. 79.
45. Nicola, N. A. Granulocyte-macrophage colony-stimulating factor (GM-CSF). In Guidebook to Cytokines and Their Receptors. N. A. Nicola, ed. Oxford Univ. Press, London, p. 171.
46. Mendel, I., A. Katz, N. Kozak, A. Ben-Nun, and M. Revel. 1998. Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice. Eur. J. Immunol. 28:1727.
47. Eugster, H. P., K. Frei, M. Kopf, H. Lassmann, and A. Fontana. 1998. IL-6 deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28:2178.
48. Zhao, M. L., J. Xia, and R. B. Fritz. 1993. Interleukin 3 and encephalitogenic activity of SJL/J myelin basic protein-specific T cell lines. J. Neurol. 43:69.